NasdaqGS - Nasdaq Real Time Price USD
Standard BioTools Inc. (LAB)
At close: November 1 at 4:00 PM EDT
After hours: November 1 at 5:09 PM EDT
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 1 | 1 | 2 |
| Avg. Estimate | -0.07 | -0.07 | -0.52 | -0.22 |
| Low Estimate | -0.08 | -0.07 | -0.52 | -0.26 |
| High Estimate | -0.06 | -0.07 | -0.52 | -0.18 |
| Year Ago EPS | -0.25 | -0.27 | -0.94 | -0.52 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 2 | 3 | 3 |
| Avg. Estimate | 43.03M | 45.6M | 171.2M | 188.17M |
| Low Estimate | 42.2M | 43.1M | 170M | 184.5M |
| High Estimate | 44.6M | 48.1M | 173M | 195M |
| Year Ago Sales | 28.19M | 46.01M | 106.34M | 171.2M |
| Sales Growth (year/est) | 52.70% | -0.90% | 61.00% | 9.90% |
Earnings History
| CURRENCY IN USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.13 | -0.11 | -0.08 | -0.09 |
| EPS Actual | -0.25 | -0.27 | -0.12 | -0.07 |
| Difference | -0.12 | -0.16 | -0.04 | 0.02 |
| Surprise % | -92.30% | -145.50% | -50.00% | 22.20% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.07 | -0.07 | -0.52 | -0.22 |
| 7 Days Ago | -0.07 | -0.06 | -0.46 | -0.21 |
| 30 Days Ago | -0.08 | -0.07 | -0.46 | -0.22 |
| 60 Days Ago | -0.08 | -0.07 | -0.46 | -0.22 |
| 90 Days Ago | -0.07 | -0.07 | 0.03 | -0.19 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | 3 | 2 |
| Up Last 30 Days | 2 | 2 | 3 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | LAB | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 72.00% | -- | -- | 5.10% |
| Next Qtr. | 74.10% | -- | -- | 11.80% |
| Current Year | 44.70% | -- | -- | 2.10% |
| Next Year | 57.70% | -- | -- | 12.30% |
| Next 5 Years (per annum) | -8.06% | -- | -- | 11.68% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Maintains | TD Cowen: Buy to Buy | 10/31/2024 |
| Maintains | TD Cowen: Buy to Buy | 8/1/2024 |
| Initiated | TD Cowen: Buy | 4/16/2024 |
| Initiated | Jefferies: Buy | 4/4/2024 |
| Initiated | Keybanc: Overweight | 7/12/2023 |
Related Tickers
QSI Quantum-Si incorporated
0.7682
+9.59%
QTRX Quanterix Corporation
13.43
+1.63%
CERS Cerus Corporation
1.5200
-3.18%
PACB Pacific Biosciences of California, Inc.
2.4400
+12.44%
BFLY Butterfly Network, Inc.
2.0300
+14.04%
CTKB Cytek Biosciences, Inc.
5.11
+3.34%
ATEC Alphatec Holdings, Inc.
8.11
+3.31%
CVRX CVRx, Inc.
13.40
+2.13%
MXCT MaxCyte, Inc.
3.7700
+5.31%
CHEMM.CO ChemoMetec A/S
408.00
+2.00%